PHARMACEUTICAL COMPOSITION FOR PROMOTING BONE TISSUE FORMATION, CONTAINING STAUNTONIA HEXAPHYLLA LEAF EXTRACT AS ACTIVE INGREDIENT

The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural...

Full description

Saved in:
Bibliographic Details
Main Authors CHOI, Chul Yung, LEE, Gyu Ok, JANG, Wook Jin, KIM, Jae Gap, KIM, Sun Oh, KIM, Jae Yong, PARK, Joon Yung, LEE, Dong Wook, SEOL, Hee Jin, KANG, Hu Won, PAN, Sang O, KIM, Hee Sook
Format Patent
LanguageEnglish
French
German
Published 13.11.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
Bibliography:Application Number: EP20140819974